Literature DB >> 10675362

Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells.

S L Tilley1, V A Wagoner, C A Salvatore, M A Jacobson, B H Koller.   

Abstract

Adenosine has potent effects on both the cardiovascular and immune systems. Exposure of tissues to adenosine results in increased vascular permeability and extravasation of serum proteins. The mechanism by which adenosine brings about these physiological changes is poorly defined. Using mice deficient in the A(3) adenosine receptor (A(3)AR), we show that increases in cutaneous vascular permeability observed after treatment with adenosine or its principal metabolite inosine are mediated through the A(3)AR. Adenosine fails to increase vascular permeability in mast cell-deficient mice, suggesting that this tissue response to adenosine is mast cell-dependent. Furthermore, this response is independent of activation of the high-affinity IgE receptor (FcepsilonR1) by antigen, as adenosine is equally effective in mediating these changes in FcepsilonR1 beta-chain-deficient mice. Together these results support a model in which adenosine and inosine induce changes in vascular permeability indirectly by activating mast cells, which in turn release vasoactive substances. The demonstration in vivo that adenosine, acting through a specific receptor, can provoke degranulation of this important tissue-based effector cell, independent of antigen activation of the high-affinity IgE receptor, supports an important role for this nucleoside in modifying the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675362      PMCID: PMC377446          DOI: 10.1172/JCI8253

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.

Authors:  J Linden; T Thai; H Figler; X Jin; A S Robeva
Journal:  Mol Pharmacol       Date:  1999-10       Impact factor: 4.436

2.  Relationship between adenosine concentration and oxygen supply in rat brain.

Authors:  R Rubio; R M Berne; E L Bockman; R R CURNISH
Journal:  Am J Physiol       Date:  1975-06

3.  Potentiation of mast cell mediator release by adenosine.

Authors:  D L Marquardt; C W Parker; T J Sullivan
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

4.  Positive inotropic response to inosine in the in situ canine heart.

Authors:  C E Jones; J X Thomas; M D Devous; C P Norris; E E Smith
Journal:  Am J Physiol       Date:  1977-10

5.  Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.

Authors:  C A Salvatore; S L Tilley; A M Latour; D S Fletcher; B H Koller; M A Jacobson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation.

Authors:  R M Mentzer; R Rubio; R M Berne
Journal:  Am J Physiol       Date:  1975-12

7.  Role of adenosine in adipose tissue circulation.

Authors:  A Sollevi; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1981-07

8.  Metabolism of circulating adenosine by the porcine isolated perfused lung.

Authors:  P G Hellewell; J D Pearson
Journal:  Circ Res       Date:  1983-07       Impact factor: 17.367

9.  Compartmentation of cardiac adenine nucleotides and formation of adenosine.

Authors:  J Schrader; E Gerlach
Journal:  Pflugers Arch       Date:  1976-12-28       Impact factor: 3.657

10.  Purine metabolism in adenosine deaminase deficiency.

Authors:  G C Mills; F C Schmalstieg; K B Trimmer; A S Goldman; R M Goldblum
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  56 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Extracellular purines from cells of seminiferous tubules.

Authors:  Daniel Pens Gelain; Luiz Fernando de Souza; Elena Aida Bernard
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

3.  Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning.

Authors:  Y Guo; R Bolli; W Bao; W J Wu; R G Black; S S Murphree; C A Salvatore; M A Jacobson; J A Auchampach
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

Review 4.  An insight into the sialome of blood-feeding Nematocera.

Authors:  José M C Ribeiro; Ben J Mans; Bruno Arcà
Journal:  Insect Biochem Mol Biol       Date:  2010-08-20       Impact factor: 4.714

5.  Extracellular inosine participates in tumor necrosis factor-alpha induced nitric oxide production in cultured Sertoli cells.

Authors:  Luiz Fernando de Souza; Daniel Pens Gelain; Fernanda Rafaela Jardim; Gisele Roncheti Ribeiro; Marcelo Zim; Elena Aida Bernard
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 6.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

7.  Anti-adipogenesis by 6-thioinosine is mediated by downregulation of PPAR gamma through JNK-dependent upregulation of iNOS.

Authors:  Jongsung Lee; Eunsun Jung; Jienny Lee; Sungran Huh; Young-Soo Kim; Yong-Woo Kim; Yeong Shik Kim; Deokhoon Park
Journal:  Cell Mol Life Sci       Date:  2009-11-26       Impact factor: 9.261

8.  Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts.

Authors:  Heather R Cross; Elizabeth Murphy; Richard G Black; John Auchampach; Charles Steenbergen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-20       Impact factor: 4.733

9.  Mast cells mediate malignant pleural effusion formation.

Authors:  Anastasios D Giannou; Antonia Marazioti; Magda Spella; Nikolaos I Kanellakis; Hara Apostolopoulou; Ioannis Psallidas; Zeljko M Prijovich; Malamati Vreka; Dimitra E Zazara; Ioannis Lilis; Vassilios Papaleonidopoulos; Chrysoula A Kairi; Alexandra L Patmanidi; Ioanna Giopanou; Nikolitsa Spiropoulou; Vaggelis Harokopos; Vassilis Aidinis; Dionisios Spyratos; Stamatia Teliousi; Helen Papadaki; Stavros Taraviras; Linda A Snyder; Oliver Eickelberg; Dimitrios Kardamakis; Yoichiro Iwakura; Thorsten B Feyerabend; Hans-Reimer Rodewald; Ioannis Kalomenidis; Timothy S Blackwell; Theodora Agalioti; Georgios T Stathopoulos
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.